Vascular abnormalities in genetically hypertensive rats begin early in life and reversal of these abnormalities during growth phase can lead to permanent amelioration of hypertension. Despite such findings the factors which affect the early growth and blood pressure responses in these animals have received little attention. Intracellular pH (pHi) is one potential factor which affects the growth and contractility of vascular cells in response to angiotensin II and other factors. Three sets of transporters regulate intracellular pH in vascular smooth muscle cells (VSMCs) as well as in other cells; Na+-H+ exchange and sodium- dependent C1- -HC03- exchange alkalinize VSMCs, whereas sodium- independent C1-HC03-exchange serves to acidify the cell. Our preliminary data suggests that Na+-H+ exchange is mediated by the NHE-1 sodium-proton antiporter and that sodium-independent C1-HC03- exchange is mediated by the anion transporters AE2 and AE3. The hypothesis for this proposal is that the onset of hypertension in genetically hypertensive animals is accompanied or induced by increases in hPi in VSMCs, and that abnormal expression or regulation of the AE and NHE proteins could help determine the hypertensive response in these animals. In order to test this hypothesis we will: 1) determine any linkage between AE2, AE3, and NHE-1 genes and hypertension in SHRSP, WKY, and cross-bred rats; 2) determine the expression of AE2 and NHE mRNAs and proteins in the resistance vessels and aortas of SHRSP and matched Wistar-Kyoto (WKY) rats before, during and after the onset of the initial growth pressure spurt; 3) assess pHi, C1-HC03- exchange, and Na+-H+ exchange in preparations of resistance vessels and aortas and ACE activity in preparations of vessels and hearts of SHRSP and WKY rats before, during and after the initial growth and blood pressure spurt, and determine the effects of angiotension II (AII), and platelet derived growth factor (PDGF) on these parameters; 4) determine intracellular Ca++ in VSMCs from resistance vessels of SHRSP and WKY rats before, during and after the initial growth and blood pressure spurt; and 5) identify the contractile differences in resistance vessels from SHRSP and WKY animals before, during and after the initial growth and blood pressure spurt in response to various manipulations which affect C1-HC03- exchange and Na+-H+ exchange. We will utilize a number of molecular genetic, biochemical, electrophysiological and physiologic techniques currently employed by the project investigators in order to provide a comprehensive analysis of pHi regulator proteins and their role in the development of genetic hypertension.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL018575-22
Application #
6241575
Study Section
Project Start
1997-07-01
Project End
1998-06-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
22
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Rocchini, Albert P; Yang, John Q; Smith, Marla J et al. (2010) Serial changes in norepinephrine kinetics associated with feeding dogs a high-fat diet. J Clin Hypertens (Greenwich) 12:117-24
Kamal, Mohamed A; Keep, Richard F; Smith, David E (2008) Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharmacokinet 23:236-42
Duan, Sheng Zhong; Ivashchenko, Christine Y; Whitesall, Steven E et al. (2007) Direct monitoring pressure overload predicts cardiac hypertrophy in mice. Physiol Meas 28:1329-39
Hu, Yongjun; Shen, Hong; Keep, Richard F et al. (2007) Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem 103:2058-65
Ennis, Steven R; Keep, Richard F (2007) Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab 27:1573-82
Shen, Hong; Ocheltree, Scott M; Hu, Yongjun et al. (2007) Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos 35:1209-16
Xiang, Jianming; Chiang, Pei-Pei; Hu, Yongjun et al. (2006) Role of PEPT2 in glycylsarcosine transport in astrocyte and glioma cultures. Neurosci Lett 396:225-9
Ennis, S R; Keep, R F (2006) Effects of 2,4-dinitrophenol on ischemia-induced blood-brain barrier disruption. Acta Neurochir Suppl 96:295-8
Carello, Katari A; Whitesall, Steven E; Lloyd, Mary C et al. (2006) Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 290:H209-16
Xiang, Jianming; Hu, Yongjun; Smith, David E et al. (2006) PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res 1122:18-23

Showing the most recent 10 out of 291 publications